Why taking patient history never ends

Publication
Article
Optometry Times JournalOptometry Times October 2019
Volume 11
Issue 10

pediatric patient
Ben Casella

I don’t like to read. I never did, and, still today, I’m more of a “wait until the movie comes out” kind of guy. I’m very fortunate in that our kids take after their mother in this regard (among others). 

I am a moderate myope, and I’m pretty sure that my contact lenses are a little stronger than they should be. This would account for my low degree of accommodative esophoria which becomes more manifest later in the day.  

You are thinking, “Cycloplege yourself and find out your true degree of myopia!” 

No. I’m not doing that, and you can’t make me. I’m not bothered by my vision. I just plain don’t like to read.

With this in mind, I saw a new patient the other day who reminded me why the patient history “never ends.” A seven-year-old presented with his mother and three siblings as new patients. The other three siblings checked out fine. The seven-year-old had no overt complaints. I asked him and his mother if there were problems with the board at school or with reading or concerns from the teacher. No one had any bad news to offer.

Previously by Dr. Casella: Make sure patients know follow-up visits may be covered 

Then his mother added, “Well, he doesn’t like reading, anyway.” I asked the child why not, and he said he just didn’t like reading.

You can tell where this is headed. As it turned out, the child was a mild latent hyperope of around 1.50 D OU. Best corrected visual acuity was 20/20 OU, and I wasn’t able to elicit frank phoria. Ocular health was unremarkable, and I released him with a prescription for as-needed wear at near. 

I asked the child’s mother to call me about a week after the glasses were dispensed, and she reported that she had noticed no changes in behavior but that he seemed to enjoy wearing them. That is one of those non-verbal cues that I pay attention to because it means I likely did something right. 

I hope I have helped create a bookworm out of this child-or that he at least doesn’t continue an aversion to reading. Had his mother not casually mentioned that little factoid about reading, I may well have accepted the report of no concerns at near and moved on. Looking back, however, I see the reality implied within that response: How can there be concerns with reading if one doesn’t read to begin with?

How do you pry for such lurking variables within a patient’s (especially a younger patient’s) visual well-being? I’m eager to know; drop me a line. In the meantime, I’ll be waiting for the movie to come out.

Read more editorials here 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.